The risk or severity of adverse effects can be increased when Miconazole is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Oxymetholone is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Isradipine is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Regorafenib is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Isavuconazole is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Isoconazole is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Dextropropoxyphene is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Troglitazone is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Astemizole is combined with Atorvastatin. The serum concentration of Atorvastatin can be decreased when it is combined with Magaldrate. The risk or severity of adverse effects can be increased when Quinidine is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Hydralazine is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Sitaxentan is combined with Atorvastatin. The serum concentration of Rifaximin can be increased when it is combined with Atorvastatin. Atorvastatin may increase the hypoglycemic activities of Glisoxepide. The serum concentration of Tolvaptan can be increased when it is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Fluticasone propionate is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Luliconazole is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Carboxyamidotriazole is combined with Atorvastatin. The serum concentration of Atorvastatin can be increased when it is combined with Darunavir. The serum concentration of Atorvastatin can be increased when it is combined with Telaprevir. The risk or severity of adverse effects can be increased when Terconazole is combined with Atorvastatin. The serum concentration of Atorvastatin can be decreased when it is combined with Magnesium Hydroxide. The serum concentration of Atorvastatin can be increased when it is combined with Posaconazole. The risk or severity of adverse effects can be increased when Methylprednisolone is combined with Atorvastatin. The serum concentration of Atorvastatin can be increased when it is combined with Daclatasvir. The risk or severity of adverse effects can be increased when Doxorubicin is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Rolitetracycline is combined with Atorvastatin. The metabolism of Atorvastatin can be decreased when combined with Amiodarone. The risk or severity of adverse effects can be increased when Efinaconazole is combined with Atorvastatin. The serum concentration of Atorvastatin can be increased when it is combined with Nafamostat. The risk or severity of adverse effects can be increased when Diazepam is combined with Atorvastatin. The serum concentration of Atorvastatin can be increased when it is combined with Omapatrilat. The serum concentration of Atorvastatin can be increased when it is combined with Sitagliptin. The serum concentration of Atorvastatin can be increased when it is combined with Fusidic Acid. The serum concentration of Atorvastatin can be increased when it is combined with Cholesterol. The risk or severity of adverse effects can be increased when Bepridil is combined with Atorvastatin. The serum concentration of Ledipasvir can be increased when it is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Delavirdine is combined with Atorvastatin. The serum concentration of Atorvastatin can be increased when it is combined with Stiripentol. The risk or severity of adverse effects can be increased when Clofazimine is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Cerivastatin is combined with Atorvastatin. The serum concentration of the active metabolites of Fesoterodine can be increased when Fesoterodine is used in combination with Atorvastatin. The risk or severity of adverse effects can be increased when Lapatinib is combined with Atorvastatin. The serum concentration of Atorvastatin can be increased when it is combined with GM6001. The serum concentration of Atorvastatin can be increased when it is combined with Enalapril. The risk or severity of adverse effects can be increased when Bromocriptine is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Vinblastine is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Caffeine is combined with Atorvastatin. The metabolism of Atorvastatin can be increased when combined with Rifabutin. The serum concentration of Doxorubicin can be increased when it is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Olaparib is combined with Atorvastatin. The metabolism of Atorvastatin can be decreased when combined with Rosiglitazone. The risk or severity of adverse effects can be increased when Dihydroergotamine is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Solithromycin is combined with Atorvastatin. The serum concentration of Atorvastatin can be increased when it is combined with 1,10-Phenanthroline. The risk or severity of adverse effects can be increased when Sulfisoxazole is combined with Atorvastatin. The serum concentration of Verapamil can be increased when it is combined with Atorvastatin. The serum concentration of Atorvastatin can be increased when it is combined with Clarithromycin. The serum concentration of Atorvastatin can be increased when it is combined with Saxagliptin. Bezafibrate may increase the myopathic rhabdomyolysis activities of Atorvastatin. The serum concentration of Ubidecarenone can be increased when it is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Levofloxacin is combined with Atorvastatin. The serum concentration of Atorvastatin can be decreased when it is combined with Cholestyramine. The serum concentration of Atorvastatin can be increased when it is combined with Dronedarone. The risk or severity of adverse effects can be increased when Azimilide is combined with Atorvastatin. The serum concentration of Digoxin can be increased when it is combined with Atorvastatin. The serum concentration of Atorvastatin can be increased when it is combined with Alpha-1-proteinase inhibitor. The serum concentration of Atorvastatin can be decreased when it is combined with Vemurafenib. The risk or severity of adverse effects can be increased when Clotiazepam is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Sertraline is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Topotecan is combined with Atorvastatin. The serum concentration of Prucalopride can be increased when it is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Valproic Acid is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Lamotrigine is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Bortezomib is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Metronidazole is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Ceritinib is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Venlafaxine is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Ifosfamide is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Aprepitant is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Topiroxostat is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Fidaxomicin is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Ivacaftor is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Cabergoline is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Josamycin is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Tolfenamic Acid is combined with Atorvastatin. The serum concentration of Silodosin can be increased when it is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Fluvastatin is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Primaquine is combined with Atorvastatin. The serum concentration of Atorvastatin can be decreased when it is combined with Tromethamine. The risk or severity of adverse effects can be increased when Tranylcypromine is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Sildenafil is combined with Atorvastatin. The serum concentration of Atorvastatin can be increased when it is combined with Vildagliptin. The risk or severity of adverse effects can be increased when Caspofungin is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Darodipine is combined with Atorvastatin. The metabolism of Atorvastatin can be increased when combined with Carbamazepine. The serum concentration of Atorvastatin can be increased when it is combined with Fosamprenavir. The risk or severity of adverse effects can be increased when Pergolide is combined with Atorvastatin. The serum concentration of Atorvastatin can be increased when it is combined with Mifepristone. The risk or severity of adverse effects can be increased when Tetracycline is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Buprenorphine is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Ergoloid mesylate is combined with Atorvastatin. The serum concentration of Atorvastatin can be decreased when it is combined with Mitotane. The serum concentration of Atorvastatin can be increased when it is combined with Apixaban. The risk or severity of adverse effects can be increased when Ezetimibe is combined with Atorvastatin. The serum concentration of Atorvastatin can be increased when it is combined with Nelfinavir. Atorvastatin may increase the anticoagulant activities of Phenindione. The risk or severity of adverse effects can be increased when Rabeprazole is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Nisoldipine is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Terfenadine is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Ziconotide is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Propofol is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Rosuvastatin is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Ciprofloxacin is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Fosaprepitant is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Lacidipine is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Bicalutamide is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Iloperidone is combined with Atorvastatin. The serum concentration of Atorvastatin can be increased when it is combined with Fosinopril. The serum concentration of Atorvastatin can be increased when it is combined with Geldanamycin. The risk or severity of adverse effects can be increased when Sulfamethoxazole is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Lomustine is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Arsenic trioxide is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Prednisolone is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Manidipine is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Zucapsaicin is combined with Atorvastatin. The serum concentration of Diltiazem can be increased when it is combined with Atorvastatin. The serum concentration of Atorvastatin can be decreased when it is combined with Siltuximab. The risk or severity of adverse effects can be increased when Tesmilifene is combined with Atorvastatin.